Cargando…
Active Specific Chemoimmunotherapy of Lymph‐node Metastasis from a Poorly Immunogenic Murine Fibrosarcoma
The fibrosarcoma MCA‐SP, which was recently induced with methylcholanthrene (MCA) in C3H/ HeJ mice, displays poor immunogenicity in in vivo prophylaxis. A cell variant MCA‐SPN1, which bears a tumor‐specific transplantation antigen (TSTA) cross‐reactive with the parental line MCA‐SP, was selected bec...
Autores principales: | Naito, Kazuyo, Oka, Takahiro, Nomi, Shinhachiro, Yamagishi, Hisakazu, Kahan, Barry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917907/ https://www.ncbi.nlm.nih.gov/pubmed/2514172 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02268.x |
Ejemplares similares
-
The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity.
por: Woodruff, M. F., et al.
Publicado: (1985) -
Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer
por: Kimura, Hideki, et al.
Publicado: (2018) -
Macrophage requirement for growth of a murine fibrosarcoma.
por: Evans, R.
Publicado: (1978) -
Immunogenicity of Protein Therapeutics: A Lymph Node Perspective
por: Fu, Kristy, et al.
Publicado: (2020) -
Elicitation of stem-like CD8(+) T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control
por: Manspeaker, Margaret P, et al.
Publicado: (2022)